Seroatlas · Human Serome Atlas

NAA20

N-alpha-acetyltransferase 20

Also known as: dJ1002M8.1, NAA20_HUMAN, NAT3, NAT5

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P61599
Gene
NAA20
Ensembl
ENSG00000173418
Chromosome
20
Canonical length
178 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Cytosol

OverviewNCBI Gene

NAT5 is a component of N-acetyltransferase complex B (NatB). Human NatB performs cotranslational N(alpha)-terminal acetylation of methionine residues when they are followed by asparagine (Starheim et al., 2008 [PubMed 18570629]).[supplied by OMIM, Apr 2009]

Canonical amino-acid sequenceUniProt

178 residues, UniProt reviewed canonical sequence.

>P61599|NAA20
     1  MTTLRAFTCD DLFRFNNINL DPLTETYGIP FYLQYLAHWP EYFIVAEAPG GELMGYIMGK
    61  AEGSVAREEW HGHVTALSVA PEFRRLGLAA KLMELLEEIS ERKGGFFVDL FVRVSNQVAV
   121  NMYKQLGYSV YRTVIEYYSA SNGEPDEDAY DMRKALSRDT EKKSIIPLPH PVRPEDIE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NAA20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.29
Highest tissue expression
173 nTPM

Expression across tissuesHPA

Tissue

  • esophagus: 173 nTPM
  • choroid plexus: 122 nTPM
  • skeletal muscle: 113 nTPM
  • parathyroid gland: 98 nTPM
  • kidney: 79 nTPM
  • liver: 77 nTPM

Single-cell type

  • esophageal apical cells: 1,709 nCPM
  • late primary spermatocytes: 858 nCPM
  • esophageal suprabasal cells: 781 nCPM
  • hofbauer cells: 431 nCPM
  • esophageal basal cells: 394 nCPM
  • early spermatids: 309 nCPM

Immune cell

  • total PBMC: 101 nTPM
  • intermediate monocyte: 98 nTPM
  • myeloid DC: 93 nTPM
  • classical monocyte: 86 nTPM
  • MAIT T-cell: 84 nTPM
  • non-classical monocyte: 82 nTPM

Brain region

  • choroid plexus: 63 nTPM
  • white matter: 42 nTPM
  • hypothalamus: 39 nTPM
  • spinal cord: 38 nTPM
  • cerebral cortex: 37 nTPM
  • thalamus: 37 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NAA20.

Disease | AllUniProt

Conditions NAA20 is implicated in, by any mechanism.

Disease | GeneticClinVar

2 pathogenic / likely-pathogenic of 28 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.03
gnomAD pLI
0.01
gnomAD missense Z
1.31
DepMap mean gene effect
-0.84
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of NAA20 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NAA20 as an antibody target. Whether an autoantibody or antibody against NAA20 could matter depends on whether native NAA20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NAA20 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NAA20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NAA20. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...